Loading News...
Volver al Panel

Moderna, Inc. (MRNA)

Valores intradiarios en tiempo real

Resumen del Mercado

From:
To:
MRNA Intraday
No data available
SímboloMRNA
Fecha de SalidaDec 7, 2018
CEOMr. Stéphane Bancel M.B.A.
Empleados a Tiempo Completo4.7k
SectorHealthcare
IndustriaBiotechnology
PaísUnited States
BolsaNasdaqGS
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Rendimiento
PeríodoRentabilidad %Cambio de Valor
1 Día
+1.18%
+2.53 US$
5 Días
+9.78%
+19.27 US$
1 Mes
+50.22%
+72.30 US$
6 Meses
+295.52%
+161.59 US$

Analizando el Mercado con IA

Evaluando los últimos 30 días de historial y métricas fundamentales de MRNA...

Estadísticas Clave
Cap. de Mercado
86.33B
Relación P/E
N/A
Rend. de Div.
0.00%
Máx. 52 Semanas
$227.46
Mín. 52 Semanas
$22.28

Consenso de Analistas

CONSENSOMantener
ALCISTA521.7%
NEUTRAL1460.9%
BAJISTA417.4%

Objetivos de Precios de Analistas a 52 Semanas

Objetivo Mín.
$45.00
Objetivo Máx.
$200.00
Actual$216.27
Objetivo Prom.$122.67

Recomendaciones de Analistas

Precio Objetivo:$122.67($45.00 - $200.00)
FirmaCalificaciónPrecio ObjetivoPotencial de AlzaFecha
Morgan StanleyEqual-Weight$95.00-56.07%7/10/2026
CitigroupSell$80.00-63.01%30/9/2026
Rothschild & CoSell$81.00-62.55%3/9/2026
Argus ResearchBuy$180.00-16.77%28/8/2026
Wolfe ResearchPeer Perform$0.00-100.00%25/8/2026
BarclaysEqual-Weight$125.00-42.20%24/8/2026
JP MorganUnderweight$77.00-64.40%21/8/2026
Goldman SachsNeutral$120.00-44.51%20/8/2026
UBSNeutral$150.00-30.64%20/8/2026
Morgan StanleyEqual-Weight$89.00-58.85%20/8/2026
Pensamientos de la Comunidad

Comparta su análisis y sentimiento sobre MRNA

Únase a la comunidad para compartir su análisis